Edit Content

Bizwit Research & Consulting LLP is a global provider of business intelligence & consulting services. We have a strong primary base of key industry leaders along with the chain of industry analysts to analyze the market trends and its future impact in order to estimates and forecast different business segments and markets. 

Global Drug Discovery Services Market to reach USD 54.4 billion by the end of 2030

Global Drug Discovery Services Market Size study & Forecast, by Process (Target Selection, Target Validation, Hit-to-Lead Identification, Lead Optimization, Candidate Validation), by Type (Chemistry Services, Biology Services), by Drug Type (Small-Molecule Drugs, Biologics), by Therapeutic Area (Oncology, Infectious Diseases, Neurological Diseases, Immunological Diseases, Endocrine and Metabolic Diseases, Respiratory Diseases, Digestive System Diseases, Cardiovascular Diseases, Genitourinary Diseases, Other Therapeutic Area), by End User (Pharmaceutical & Biotechnology Companies, Academic Institutes, Other End Users), and Regional Analysis, 2023-2030

Product Code: HLSHS-12556219
Publish Date: 10-08-2023
Page: 200

Global Drug Discovery Services Market is valued approximately USD 17.9 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 14.9% over the forecast period 2023-2030. Drug discovery services encompass a range of scientific and technological solutions provided by specialized organizations to support the identification, development, and optimization of new drug candidates. These services involve various stages of the drug discovery process, including target identification and validation, high-throughput screening, hit-to-lead optimization, medicinal chemistry, ADME (absorption, distribution, metabolism, and excretion) studies, and preclinical development. Through a combination of expertise, advanced technologies, and research methodologies, drug discovery services aim to accelerate the discovery and development of safe and effective drugs, ultimately advancing healthcare and addressing unmet medical needs. The market drivers boosting the market growth are increasing R&D expenditure and growing prevalence of chronic diseases.

According to Statista, in 2022, the total spending on pharmaceutical R&D accounted to USD 238 billion and is expected to amount to USD 285 billion in 2028. The rising incidence of chronic diseases such as cancer, cardiovascular diseases, and neurological disorders has created a significant need for innovative and effective drug therapies. According to Statista, the cancer deaths worldwide are projected to rise from nearly 10 million in 2022 to over 16 million by 2040. Moreover, expansion of Biologics and Cell-Based therapies and increasing demand for personalized medicines may create lucrative opportunities. However, the high cost of Drug Discovery and limited availability of skilled workforce stifles market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Drug Discovery Services Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to a well-established pharmaceutical sector, ongoing research and development projects, significant R&D spending, expansion of the biosimilar and generics markets, and increasing outsourcing of R&D services by pharmaceutical and biopharmaceutical companies in the region. However, Asia Pacific is expected to become the fastest growing during the forecast period, owing to factors such as growing pharmaceutical industry, and increasing outsourcing drug discovery activities to specialized service providers to streamline operations, reduce costs, and access specialized expertise.

Major market player included in this report are:
Laboratory Corporation of America Holdings
Charles River Laboratories International, Inc.
Eurofins Scientific SE
GVK Biosciences Private Limited
Albany Molecular Research Inc. (AMRI)
Domainex Ltd.
GenScript Biotech Corporation
Aurigene Discovery Technologies Ltd.
WuXi AppTec
Evotec SE

Recent Developments in the Market:
Ø In February 2023, Evotec SE and Related Sciences have extended their collaborative partnership to pursue an integrated multi-target drug discovery agreement. Their joint objective is to identify, research, and advance highly targeted therapies to address unmet medical requirements.
Ø In January 2023, Charles River Laboratories completed the acquisition of SAMDI Tech, Inc., a provider of label-free high-throughput screening (HTS) solutions for drug discovery research. This acquisition enhances Charles River Laboratories’ capabilities in label-free HTS MS platforms and expands its portfolio of drug discovery solutions, resulting in a comprehensive library of offerings.

Global Drug Discovery Services Market Report Scope:
ü Historical Data – 2020 – 2021
ü Base Year for Estimation – 2022
ü Forecast period – 2023-2030
ü Report Coverage – Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
ü Segments Covered – Process, Type, Drug Type, Therapeutic Area, End User, Region
ü Regional Scope – North America; Europe; Asia Pacific; Latin America; Middle East & Africa
ü Customization Scope – Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Process:
Target Selection
Target Validation
Hit-to-Lead Identification
Lead Optimization
Candidate Validation
By Type:
Chemistry Services
Biology Services
By Drug Type:
Small-Molecule Drugs
By Therapeutic Area:
Infectious Diseases
Neurological Diseases
Immunological Diseases
Endocrine and Metabolic Diseases
Respiratory Diseases
Digestive System Diseases
Cardiovascular Diseases
Genitourinary Diseases
Other Therapeutic Area
By End User:
Pharmaceutical & Biotechnology Companies
Academic Institutes
Other End Users

By Region:

North America


Asia Pacific
South Korea

Latin America

Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
1.2.1. Drug Discovery Services Market, by Region, 2020-2030 (USD Billion)
1.2.2. Drug Discovery Services Market, by Process, 2020-2030 (USD Billion)
1.2.3. Drug Discovery Services Market, by Type, 2020-2030 (USD Billion)
1.2.4. Drug Discovery Services Market, by Drug Type, 2020-2030 (USD Billion)
1.2.5. Drug Discovery Services Market, by Therapeutic Area, 2020-2030 (USD Billion)
1.2.6. Drug Discovery Services Market, by End User, 2020-2030 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Drug Discovery Services Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Drug Discovery Services Market Dynamics
3.1. Drug Discovery Services Market Impact Analysis (2020-2030)
3.1.1. Market Drivers Increasing R&D expenditure Growing prevalence of chronic diseases
3.1.2. Market Challenges High Cost of Drug Discovery Limited availability of skilled workforce
3.1.3. Market Opportunities Expansion of Biologics and Cell-Based Therapies Increasing demand for personalized medicine
Chapter 4. Global Drug Discovery Services Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter’s 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion
Chapter 5. Global Drug Discovery Services Market, by Process
5.1. Market Snapshot
5.2. Global Drug Discovery Services Market by Process, Performance – Potential Analysis
5.3. Global Drug Discovery Services Market Estimates & Forecasts by Process 2020-2030 (USD Billion)
5.4. Drug Discovery Services Market, Sub Segment Analysis
5.4.1. Target Selection
5.4.2. Target Validation
5.4.3. Hit-to-Lead Identification
5.4.4. Lead Optimization
5.4.5. Candidate Validation
Chapter 6. Global Drug Discovery Services Market, by Type
6.1. Market Snapshot
6.2. Global Drug Discovery Services Market by Type, Performance – Potential Analysis
6.3. Global Drug Discovery Services Market Estimates & Forecasts by Type 2020-2030 (USD Billion)
6.4. Drug Discovery Services Market, Sub Segment Analysis
6.4.1. Chemistry Services
6.4.2. Biology Services
Chapter 7. Global Drug Discovery Services Market, by Drug Type
7.1. Market Snapshot
7.2. Global Drug Discovery Services Market by Drug Type, Performance – Potential Analysis
7.3. Global Drug Discovery Services Market Estimates & Forecasts by Drug Type 2020-2030 (USD Billion)
7.4. Drug Discovery Services Market, Sub Segment Analysis
7.4.1. Small-Molecule Drugs
7.4.2. Biologics
Chapter 8. Global Drug Discovery Services Market, by Therapeutic Area
8.1. Market Snapshot
8.2. Global Drug Discovery Services Market by Therapeutic Area, Performance – Potential Analysis
8.3. Global Drug Discovery Services Market Estimates & Forecasts by Therapeutic Area 2020-2030 (USD Billion)
8.4. Drug Discovery Services Market, Sub Segment Analysis
8.4.1. Oncology
8.4.2. Infectious Diseases
8.4.3. Neurological Diseases
8.4.4. Immunological Diseases
8.4.5. Endocrine and Metabolic Diseases
8.4.6. Respiratory Diseases
8.4.7. Digestive System Diseases
8.4.8. Cardiovascular Diseases
8.4.9. Genitourinary Diseases
8.4.10. Other Therapeutic Area
Chapter 9. Global Drug Discovery Services Market, by End User
9.1. Market Snapshot
9.2. Global Drug Discovery Services Market by End User, Performance – Potential Analysis
9.3. Global Drug Discovery Services Market Estimates & Forecasts by End User 2020-2030 (USD Billion)
9.4. Drug Discovery Services Market, Sub Segment Analysis
9.4.1. Pharmaceutical & Biotechnology Companies
9.4.2. Academic Institutes
9.4.3. Other End Users
Chapter 10. Global Drug Discovery Services Market, Regional Analysis
10.1. Top Leading Countries
10.2. Top Emerging Countries
10.3. Drug Discovery Services Market, Regional Market Snapshot
10.4. North America Drug Discovery Services Market
10.4.1. U.S. Drug Discovery Services Market Process breakdown estimates & forecasts, 2020-2030 Type breakdown estimates & forecasts, 2020-2030 Drug Type breakdown estimates & forecasts, 2020-2030 Therapeutic Area breakdown estimates & forecasts, 2020-2030 End User breakdown estimates & forecasts, 2020-2030
10.4.2. Canada Drug Discovery Services Market
10.5. Europe Drug Discovery Services Market Snapshot
10.5.1. U.K. Drug Discovery Services Market
10.5.2. Germany Drug Discovery Services Market
10.5.3. France Drug Discovery Services Market
10.5.4. Spain Drug Discovery Services Market
10.5.5. Italy Drug Discovery Services Market
10.5.6. Rest of Europe Drug Discovery Services Market
10.6. Asia-Pacific Drug Discovery Services Market Snapshot
10.6.1. China Drug Discovery Services Market
10.6.2. India Drug Discovery Services Market
10.6.3. Japan Drug Discovery Services Market
10.6.4. Australia Drug Discovery Services Market
10.6.5. South Korea Drug Discovery Services Market
10.6.6. Rest of Asia Pacific Drug Discovery Services Market
10.7. Latin America Drug Discovery Services Market Snapshot
10.7.1. Brazil Drug Discovery Services Market
10.7.2. Mexico Drug Discovery Services Market
10.8. Middle East & Africa Drug Discovery Services Market
10.8.1. Saudi Arabia Drug Discovery Services Market
10.8.2. South Africa Drug Discovery Services Market
10.8.3. Rest of Middle East & Africa Drug Discovery Services Market

Chapter 11. Competitive Intelligence
11.1. Key Company SWOT Analysis
11.1.1. Company 1
11.1.2. Company 2
11.1.3. Company 3
11.2. Top Market Strategies
11.3. Company Profiles
11.3.1. Laboratory Corporation of America Holdings Key Information Overview Financial (Subject to Data Availability) Product Summary Recent Developments
11.3.2. Charles River Laboratories International, Inc.
11.3.3. Eurofins Scientific SE
11.3.4. GVK Biosciences Private Limited
11.3.5. Albany Molecular Research Inc. (AMRI)
11.3.6. Domainex Ltd.
11.3.7. GenScript Biotech Corporation
11.3.8. Aurigene Discovery Technologies Ltd.
11.3.9. WuXi AppTec
11.3.10. Evotec SE
Chapter 12. Research Process
12.1. Research Process
12.1.1. Data Mining
12.1.2. Analysis
12.1.3. Market Estimation
12.1.4. Validation
12.1.5. Publishing
12.2. Research Attributes
12.3. Research Assumption

At Bizwit Research and Consultancy, we employ a thorough and iterative research methodology with the goal of minimizing discrepancies, ensuring the provision of highly accurate estimates and predictions over the forecast period. Our approach involves a combination of bottom-up and top-down strategies to effectively segment and estimate quantitative aspects of the market, utilizing our proprietary data & AI tools. Our Proprietary Tools allow us for the creation of customized models specific to the research objectives. This enables us to develop tailored statistical models and forecasting algorithms to estimate market trends, future growth, or consumer behavior. The customization enhances the accuracy and relevance of the research findings.
We are dedicated to clearly communicating the purpose and objectives of each research project in the final deliverables. Our process begins by identifying the specific problem or challenge our client wishes to address, and from there, we establish precise research questions that need to be answered. To gain a comprehensive understanding of the subject matter and identify the most relevant trends and best practices, we conduct an extensive review of existing literature, industry reports, case studies, and pertinent academic research.
Critical elements of methodology employed for all our studies include:
Data Collection:
To determine the appropriate methods of data collection based on the research objectives, we consider both primary and secondary sources. Primary data collection involves gathering information directly from various industry experts in core and related fields, original equipment manufacturers (OEMs), vendors, suppliers, technology developers, alliances, and organizations. These sources encompass all segments of the value chain within the specific industry. Through in-depth interviews, we engage with key industry participants, subject-matter experts, C-level executives of major market players, industry consultants, and other relevant experts. This allows us to obtain and validate critical qualitative and quantitative information while evaluating market prospects. AI and Big Data are instrumental in our primary research, providing us with powerful tools to collect, analyze, and derive insights from data efficiently. These technologies contribute to the advancement of research methodologies, enabling us to make data-driven decisions and uncover valuable findings.
In addition to primary sources, we extensively utilize secondary sources to enhance our research. These include directories, databases, journals focusing on related industries, company newsletters, and information portals such as Bloomberg, D&B Hoovers, and Factiva. These secondary sources enable us to identify and gather valuable information for our comprehensive, technical, market-oriented, and commercial study of the market. Additionally, we utilize AI algorithms to automate the collection of vast amounts of data from various sources such as surveys, social media platforms, online transactions, and web scraping. And employ Big Data technologies for storage and processing of large datasets, ensuring that no valuable information is missed during the data collection process.
Data Analysis:
Our team of experts carefully examine the gathered data using suitable statistical techniques and qualitative analysis methods. For quantitative analysis, we employ descriptive statistics, regression analysis, and other advanced statistical methods, depending on the characteristics of the data. This analysis may also incorporate the utilization of AI tools and big data analysis techniques to extract meaningful insights.
To ensure the accuracy and reliability of our findings, we extensively leverage data science techniques, which help us minimize discrepancies and uncertainties in our analysis. We employ Data Science to clean and preprocess the data, ensuring its quality and reliability. This involves handling missing data, removing outliers, standardizing variables, and transforming data into suitable formats for analysis. The application of data science techniques enhances our accuracy, efficiency, and depth of analysis, enabling us to stay competitive in dynamic market environments.
Market Size Estimation:
Our proprietary data tools play a crucial role in deriving our market estimates and forecasts. Each study involves the creation of a unique and customized model. The model incorporates the gathered information on market dynamics, technology landscape, application development, and pricing trends. AI techniques, such as machine learning and deep learning, aid us to analyze patterns within the data to identify correlations, trends, and relationships. By recognizing patterns in consumer behavior, purchasing habits, or market dynamics, our AI algorithms aid us in more precise estimations of market size. These factors are simultaneously analyzed within the model, allowing for a comprehensive assessment. To quantify their impact over the forecast period, correlation, regression, and time series analysis are employed.
To estimate and validate the market size, we employ both top-down and bottom-up approaches. The preference is given to a bottom-up approach, where key regional markets are analyzed as separate entities. This data is then integrated to obtain global estimates. This approach is crucial as it provides a deep understanding of the industry and helps minimize errors.
In our forecasting process, we consider various parameters such as economic tools, technological analysis, industry experience, and domain expertise. By taking all these factors into account, we strive to produce accurate and reliable market forecasts. When forecasting, we take into consideration several parameters, which include:
Market driving trends and favorable economic conditions
Restraints and challenges that are expected to be encountered during the forecast period.
Anticipated opportunities for growth and development
Technological advancements and projected developments in the market
Consumer spending trends and dynamics
Shifts in consumer preferences and behaviors.
The current state of raw materials and trends in supply versus pricing
Regulatory landscape and expected changes or developments.
The existing capacity in the market and any expected additions or expansions up to the end of the forecast period.
To assess the market impact of these parameters, we assign weights to each one and utilize weighted average analysis. This process allows us to quantify their influence on the market and derive an expected growth rate for the forecasted period. By considering these various factors and applying a weighted analysis approach, we strive to provide accurate and reliable market forecasts.
Insight Generation & Report Presentation:
After conducting the research, our experts analyze the findings in relation to the research objectives and the specific needs of the client. They generate valuable insights and recommendations that directly address the client’s business challenges. These insights are carefully connected to the research findings to provide a comprehensive understanding.
Next, we create a well-structured research report that effectively communicates the research findings, insights, and recommendations to the client. To enhance clarity and comprehension, we utilize visual aids such as charts, graphs, and tables. These visual elements are employed to present the data in an engaging and easily understandable format, ensuring that the information is accessible and visually appealing to the client. Our aim is to deliver a clear and concise report that conveys the research findings effectively and provides actionable recommendations to meet the client’s specific needs.

Need Assistance

Contact Person -
Krishant Mennon
Call us @
+ 91 99931 15879
Email: sales@bizwitresearch.com


Why Choose Us?

Quality over Quantity

Backed by 60+ paid data sources our reports deliver crisp insights with no compromise quality.

Analyst Support

24x7 Chat Support plus
free analyst hours with every purchase

Flawless Methodology

Our 360-degree approach of market study, our research methods leave stones unturned.

Enquiry Now